Source disclosure: February 13, 2026
HOGY MEDICAL CO.,LTD. [3593.T]
TOKYO — Hogy Medical Co., Ltd. announced on February 13, 2026, that it supports and recommends shareholders to tender their shares in response to TCG2509 Corporation's public offer for its common stock. The company made this statement following several previous announcements regarding the same tender offer.
The latest announcement comes after TCG2509 Corporation submitted an amended filing to the Kanto Regional Finance Bureau Director on February 13, 2026. This amendment was necessitated by changes to the Foreign Exchange and Foreign Trade Law (Foreign Exchange Act), which allowed for a shortened waiting period under Article 27, Paragraph 2, Subparagraph of the law. As a result, TCG2509 Corporation can now acquire Hogy Medical’s ordinary shares earlier than initially planned. Consequently, the tender offer period has been extended from February 5, 2026, to March 2, 2026, making the total duration of the tender offer 45 business days.
In addition to extending the tender offer period, the company provided updated information on the rationale behind supporting the tender offer. According to Hogy Medical, the decision is based on explanations received from TCG2509 Corporation. Specifically, the revised timeline reflects two stages of condition modifications: "Buyout Condition Change (1)" and "Buyout Condition Change (2)." These changes were prompted by regulatory approvals and subsequent adjustments to the tender offer schedule.
Furthermore, the company emphasized measures taken to ensure fairness in the tender process and protect shareholder interests. It highlighted that competitive bidding procedures had already secured opportunities for other potential buyers. Additionally, despite the legal minimum tender period being set at 20 business days, TCG2509 Corporation initially proposed a 30-business-day window, which was later extended to 40 business days due to the first modification and further to 45 business days due to the second modification. This extension aims to provide ample time for shareholders to consider their options thoroughly.
AI-translated content. 🟢 Confidence: High See terms • Original filing